Comparison of 10-year overall survival between patients with G1 and G2 grade Ta bladder tumors.

Autor: Balan D; Department of Cell and Molecular Biology Department of Urology, University of Medicine and Pharmacy, Tirgu Mures, Romania Department of Urology, University of Pécs, Pécs, Hungary Department of Epidemiology, University of Medicine and Pharmacy, Tirgu Mures, Romania Division of Urology, European Institute of Oncology, Milan, Italy Department of Urology, Medical University of Vienna, Vienna, Austria Department of Emergency and Organ Transplantation-Urology, Andrology and Kidney Transplantation Unit, University of Bari, Bari Department of Urology, Sapienza University of Rome, Rome, Italy Department of Histology, University of Medicine and Pharmacy, Tirgu Mures, Romania., Martha O, Chibelean CB, Tataru S, Voidezan S, Sin A, Matei VD, Vartolomei MD, Lucarelli G, Cioffi A, Del Giudice F, De Berardinis E, Borda A, Busetto GM, Ferro M, Pytel A, Porav-Hodade D

Publikováno v: Medicine [Medicine (Baltimore)] 2018 Apr; Vol. 97 (16), pp. e0522.

Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy.

Autor: Jereczek-Fossa BA; Department of Radiotherapy, European Institute of Oncology, Milan, Italy., Zerini D, Vavassori A, Fodor C, Santoro L, Minissale A, Cambria R, Cattani F, Garibaldi C, Serafini F, Matei VD, de Cobelli O, Orecchia R

Publikováno v: International journal of radiation oncology, biology, physics [Int J Radiat Oncol Biol Phys] 2009 May 01; Vol. 74 (1), pp. 115-25. Date of Electronic Publication: 2008 Nov 12.

Impact of pathological tumor stage for salvage radiotherapy after radical prostatectomy in patients with prostate-specific antigen < 1.0 ng/ml.

Publikováno v: Radiation Oncology. 2011, Vol. 6 Issue 1, p150-157. 8p. 4 Charts, 6 Graphs.